Trial Parameters
Condition Giant Cell Arteritis
Sponsor Wuerzburg University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-11-14
Completion 2030-07-31
All Conditions
Brief Summary
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Eligibility Criteria
Inclusion Criteria: * Age greater or similar to 18 years * Primary diagnosis of GCA or PMR Exclusion Criteria: * Age under 18 years * lack of capacity to consent
Related Trials
NCT06011512
Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.
View Trial →
NCT06004154
Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHort
View Trial →
NCT05865054
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
View Trial →